Is Aprtoninin treatment worth the risk of kideny failure, stroke, or heart attack?

Here is yet one more reason not to use Trasylol, a cardiac surgery drug linked to a large increase in the risk of renal kidney failure. According to a recent study by Australian doctors, it is reported that for a strained or inflamed Achilles tendon, injections of aprotinin do not seem to do much to shorten recovery time. Read More...

While Bayer patented in 1899, still generates more than $1 billion per year, Bayer had to recall its cholesterol drug Baycol, in 2001, to fight off a bevy of lawsuits. Antibiotic Cipro fell to generic competition. Erectile dysfunction pill Levitra was a flop. This year, the company has faced controversy over its drug Trasylol, used in heart surgery, which a study in The New England Journal of Medicine said may pose significant risks to patients. Read more...

And now, researchers' findings advance cardiology research -- Study 1: An association between aprotinin and serious end-organ damage indicates that continued use is not prudent. According to recent research from the United States, "The majority of patients undergoing surgical treatment for ST-elevation myocardial infarction receive antifibrinolytic therapy to limit blood loss. This approach appears counterintuitive to the accepted medical treatment of the same condition -namely, fibrinolysis to limit thrombosis." "Despite this concern, no independent, large-scale safety assessment has been undertaken," noted D.T. Mangano and colleagues at the Ischemia ... Read More about this Aprotinin Study...